Who is LUCENTIS for?

Genentech USA, Inc., Lucentis

Source: www.lucentis.com/lucentis/

Who is LUCENTIS for?

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema following Retinal Vein Occlusion (RVO).

What important safety information should I know about LUCENTIS?

LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.

Although not common, LUCENTIS patients have had eye- and non-eye-related blood clots (heart attacks, strokes, and death).

Some patients have increases in eye pressure within 1 hour of an injection.

Serious side effects include inflammation inside the eye, and rarely, problems related to the injection procedure, such as developing a cataract. These can make your vision worse.

The most common side effects to your eye are increased redness in the whites of your eye, eye pain, small specks in vision, the feeling that something is in your eye. The most common non-eye-related side effects are nose and throat infections, headache, and respiratory (lung) infections.

If your eye becomes red, sensitive to light, painful, or has a change in vision, you should call or visit your eye doctor right away.

For additional safety information, please talk to your doctor and also see the LUCENTIS full prescribing information.